Goldman Sachs is out with its report today on Brookdale Senior Living BKD, maintaining Buy.
In a note to clients, Goldman Sachs writes, "We lower our 2Q CFFO estimate for Buy-rated leading senior housing
operator Brookdale Senior Living but maintain our positive investment view and believe that BKD still offers the most compelling absolute upside in our CRE/REITs coverage. In summary, we still recommend investors buy
BKD for 22% upside to our unchanged 12-month price target of $30."
Shares of BKD closed Tuesday at $24.29, down 1.26% from Friday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst RatingsBrookdale Senior LivingGoldman SachsHealth CareHealth Care Facilities
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in